The corporate which provides the digital affected person report system utilized by nearly all of GPs in Britain is being circled by a pack of potential patrons, simply two years after it final modified arms.
Optum UK’s enterprise contains EMIS, which was taken over by the UnitedHealth subsidiary in 2023 in a deal value about £1.2bn.
The takeover was engineered beneath the stewardship of Sir Andrew Witty, the previous GlaxoSmithKline boss who just lately stepped down as UnitedHealth’s chief government.
The US-listed firm’s inventory has fallen by greater than a 3rd over the past yr, leaving it with a market capitalisation at Thursday’s shut of slightly below $331bn.
Financial institution of America is known to have been engaged to advise on the sale course of.
One non-public fairness supply mentioned that UnitedHealth was eager to recoup the 2023 buy value.
The possible sale fashioned a part of efforts by Sir Andrew’s successor, Stephen Hemsley, to arrest the corporate’s alarming valuation decline, they added.
Optum’s takeover of EMIS deal was permitted in September 2023 by British competitors regulators following an in-depth Section 2 investigation
A spokesperson for Optum mentioned: “We do not comment on market speculation or rumours.”
A number of different main monetary buyers are additionally understood to be within the early phases of exploring bids for the enterprise.
Blackstone declined to remark.
